USA Compounding Pharmacies Market Set for Remarkable Growth, Projected to Reach USD 23,430.35 Million by 2033

The USA compounding pharmacies market is on a trajectory of robust growth, driven by the increasing demand for personalized medication solutions. According to the latest market analysis, the market is expected to be valued at USD 11,099.0 million by the end of 2023, marking a significant milestone in the sector’s expansion.

Over the next decade, from 2023 to 2033, the market is forecasted to grow at a compound annual growth rate (CAGR) of 7.8%, reaching an impressive USD 23,430.35 million by 2033. This sustained growth highlights the rising importance of customized pharmaceutical solutions that cater to individual patient needs, enhancing both medication safety and efficacy.

Compounding pharmacies play a crucial role in the healthcare ecosystem, offering medications that are not readily available through mass-market channels. These specialized pharmacies provide tailored solutions, such as customized dosages and alternative ingredients, to meet the specific needs of patients who may not find suitable options in commercially available medications. By doing so, they effectively bridge a critical gap in healthcare delivery.

The increasing focus on personalized medicine further underscores the importance of compounding pharmacies in shaping the future of healthcare. As the demand for tailored therapeutic solutions continues to rise, these pharmacies are expected to have a profound impact on improving patient outcomes by ensuring that medications are precisely aligned with individual health requirements.

With this impressive growth outlook, compounding pharmacies are poised to become key players in advancing patient-centered healthcare, meeting the growing demand for safe, effective, and personalized treatments.

Key Drivers of Market Growth:

• Rising Prevalence of Chronic Diseases: The increasing incidence of chronic conditions is fueling the demand for tailored treatment solutions.
• Need for Specialized Treatments: There is a growing need for customized medications for rare diseases and conditions.
• Medication Alternatives: The rising prevalence of allergies and intolerances drives demand for alternative medication solutions.

Market Highlights:

• The USA compounding pharmacies market grew at a CAGR of 5.2% from 2018 to 2022.
• The oral and topical medicine sectors are anticipated to dominate, with the sector’s regional market share exceeding 60% in 2022.
• Hormone Replacement Therapy (HRT) saw an increase in market share, reaching 39% in 2022.
• Regular pharmacies accounted for over 27% of the market share in 2022.

Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI), commented, “The market will see substantial growth during the projected period due to the rising prevalence of chronic illnesses like cancer and increased financing for compounding pharmacies in the USA.”

Get the Latest on USA Compounding Pharmacies: Our Full Report Highlights Key Trends and Insights!

Competitive Landscape:

Prominent players in the USA compounding pharmacies market include:

• Avella Specialty Pharmacy
• Central Admixture Pharmacy Services Inc.
• Hoye’s Pharmacy
• Vertisis Custom Pharmacy
• Smith Caldwell Drug Store
• Sixth Avenue Medical Pharmacy
• Cantrell Drug Company
• Clinigen Group
• Dougherty’s Pharmacy
• Fagron N.V.

Recent Developments:

• Adamis Pharmaceuticals Corporation announced in 2021 the sale of US Compounding Inc.’s assets for USD 15 million.
• Harrow revealed in 2023 that its subsidiary ImprimisRx will offer patent-pending compounded Atropine formulations.
• Nephron Pharmaceuticals Corporation launched a new syringe presentation in 2022 as part of its successful Nephron 503B Outsourcing Facility business.

Market Segmentation:

• By Product: Oral Medication (Solid, Liquid), Topical Medication, Injectable, Mouthwashes, Nasal, Ocular, Otic, Suppositories and Enemas.
• By Pharmacy Type: 503A Pharmacy, 503B Pharmacy.
• By Application: Adults, Pediatrics, Geriatrics, Veterinary.
• By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Others.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube